Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 9/19/2023CDE Solicits Comments for the Latest Adjustment Catalog of Reference F...
  • 9/18/2023GenScript Expands Range of Reagent Services, Adding Circular RNA and L...
  • 9/15/2023JW Therapeutics and 2Seventy Bio Announce Strategic Partnership to Acc...
  • 9/15/2023Cure Genetics, Frametact to Develop Brain Disease Gene Therapies in $6...
  • 9/15/2023Drug R&D and Product Registration News Digest 09/2023 (2)
  • 9/14/2023China to Manage Monkeypox as Category B Infectious Disease as Covid-19 (Free)
  • 9/13/2023NHSA Issues the Notice on Further Advancing the Intelligent Review and...
  • 9/13/2023LIB Thera and Hasten Biopharma Announce $325M Strategic Collaboration ...
  • 9/13/2023Clover Biopharma Launches Quadrivalent Influenza Vaccine in Mainland C...
  • 9/13/2023AriBio, Shanghai Pharma to Commercialize Oral Alzheimer's Drug AR1001
  • 9/13/2023Exelixis and Insilico Enter Global Licensing Pact for Anticancer Candi...
  • 9/12/2023Chinese Pharma Companies Expand Foothold in Africa
  • 9/12/2023CDE Solicits Comments on the Technical Guidelines for Clinical Study o...
  • 9/12/2023CDE Solicits Comments on the Technical Guidelines for Clinical Study o...
  • 9/12/2023China Adjusts the Catalog of Narcotic and Psychotropic Drugs
  • 9/8/2023Drug R&D and Product Registration News Digest 09/2023 (1)
  • 9/8/2023Recent Official and Executive Moves
  • 9/7/2023MSD Plans to Boost New Product Launch and Pharma R&D in China
  • 9/7/2023CDE Releases the Annual Report on New Drug Registration Clinical Trial...
  • 9/6/2023Pfizer Faces Whistleblower Lawsuit over Alleged FCPA Violations in Chi...
  • 9/6/2023NMPA Solicits Comments on the Guidelines for the Inspection of Third-P...
  • 9/5/2023NMPA Issues Announcement for Applicability of ICH Guidelines Q9(R1)
  • 9/5/2023NMPA Issues the Announcement for Applicability of ICH Guidelines S12
  • 9/4/2023CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...
  • 9/1/2023Recent Executive Moves
  • 9/1/2023NHSA Issues the List of Drugs Passing Preliminary Form Evaluation for ...
  • 9/1/2023CDE Solicits Comments on the Technical Guidelines for Post-Marketing P...
  • 9/1/2023SAMR Solicits Public Comments on the Proposed Compliance Guidelines fo...
  • 8/31/2023Financial-related Company News Digest (August 2023)
  • 8/31/2023Drug R&D and Product Registration News Digest August 2023 (5)
  • Page:28/33 Total number of articles:961: [First][<<] [26] [27] [28] [29] [30] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group